Former Head of Pharmaceutical Research USA at Bayer HealthCare, Joe Catino, Ph.D., will be giving a presentation at Yale next month regarding his current company, Helix Therapeutics. Dr. Catino is the President and CEO of Helix Therapeutics, and he will be joined by Peter Glazer, M.D., Ph.D., Yale professor and Helix's founder.
Members of the public, including BRC alums, are welcome to attend. A detailed agenda is at http://curenet.org/curenews/0910helix/, but the key points are:
Wednesday, November 18, 2009
The Anlyan Center Auditorium, Yale Medical School
3:30 P.M. Registration
4:00 P.M. Seminar
5:00 P.M. Networking, Refreshments & Wine Bar
Registration is free, but please RSVP in advance. E-mail to biohaven@yale.edu or call the Yale Office of Cooperative Research main number at 1-203-785-6209.
